The large spectrum of eIF2B-related diseases
- PMID: 16246171
- DOI: 10.1042/BST20060022
The large spectrum of eIF2B-related diseases
Abstract
eIF2B (eukaryotic initiation factor 2B) is a GEF (guanine nucleotide-exchange factor) that plays, with its substrate eIF2, a key regulatory role in the translation initiation phase of protein synthesis. The importance of correct control of eIF2 and eIF2B for normal physiology is underlined by the recent involvement of the five genes that encode the five eIF2B subunits in a severe autosomal recessive neurodegenerative disease, described in young children as CACH (childhood ataxia with central nervous system hypomyelination)/VWM (leukoencephalopathy with vanishing white matter) syndrome. The syndrome is characterized by episodes of rapid deterioration during febrile illnesses or following head trauma and symmetrical demyelination of the brain white matter with cavitation aspects, leading to a progressive vanishing of the white matter replaced by CSF (cerebrospinal fluid). However, a wide clinical spectrum has been observed in the 148 patients presently reported, from congenital forms with rapid death to adult-onset forms with slow mental decline and progressive motor dysfunction, sometimes associated with congenital eye abnormalities or ovariodysgenesis. So far, 77 different mutations in each of the five EIF2B genes (EIF2B1-5), encoding subunits eIF2Balpha-epsilon, have been found, with two-thirds affecting the eIF2Bepsilon subunit. The correlation found between the level of GEF activity of eIF2B in the mutated white blood cells and the age at disease onset suggests a direct role of the abnormal translation control in the pathophysiology of the disease.
Similar articles
-
Dominant form of vanishing white matter-like leukoencephalopathy.Ann Neurol. 2005 Oct;58(4):634-9. doi: 10.1002/ana.20573. Ann Neurol. 2005. PMID: 16047349
-
The spectrum of mutations for the diagnosis of vanishing white matter disease.Neurol Sci. 2006 Sep;27(4):271-7. doi: 10.1007/s10072-006-0683-y. Neurol Sci. 2006. PMID: 16998732 Review.
-
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.Brain. 2009 Aug;132(Pt 8):2161-9. doi: 10.1093/brain/awp171. Brain. 2009. PMID: 19625339
-
Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.Eur J Hum Genet. 2004 Jul;12(7):561-6. doi: 10.1038/sj.ejhg.5201189. Eur J Hum Genet. 2004. PMID: 15054402
-
[CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].Rev Neurol (Paris). 2007 Sep;163(8-9):793-9. doi: 10.1016/s0035-3787(07)91461-7. Rev Neurol (Paris). 2007. PMID: 17878805 Review. French.
Cited by
-
A Missense Mutation in PPP1R15B Causes a Syndrome Including Diabetes, Short Stature, and Microcephaly.Diabetes. 2015 Nov;64(11):3951-62. doi: 10.2337/db15-0477. Epub 2015 Jul 9. Diabetes. 2015. PMID: 26159176 Free PMC article.
-
Vanishing white matter leukodystrophy due to novel EIF2B4 mutation in an adult female.J Neurosci Rural Pract. 2023 Jan-Mar;14(1):191-193. doi: 10.25259/JNRP-2022-2-48. Epub 2023 Jan 9. J Neurosci Rural Pract. 2023. PMID: 36891084 Free PMC article. No abstract available.
-
Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB.Mol Cell. 2020 Feb 20;77(4):875-886.e7. doi: 10.1016/j.molcel.2019.11.008. Epub 2019 Dec 10. Mol Cell. 2020. PMID: 31836389 Free PMC article.
-
LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter.Mol Med. 2022 Sep 13;28(1):112. doi: 10.1186/s10020-022-00521-5. Mol Med. 2022. PMID: 36100884 Free PMC article.
-
Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes.Int J Environ Res Public Health. 2020 Jun 2;17(11):3951. doi: 10.3390/ijerph17113951. Int J Environ Res Public Health. 2020. PMID: 32498447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical